- Home
- CRVO vs MSD Comparison
CRVO vs MSD Comparison
Compare CRVO & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- MSD
- Stock Information
- Founded
- CRVO 2001
- MSD 1993
- Country
- CRVO United States
- MSD United States
- Employees
- CRVO N/A
- MSD N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- MSD Trusts Except Educational Religious and Charitable
- Sector
- CRVO Health Care
- MSD Finance
- Exchange
- CRVO Nasdaq
- MSD Nasdaq
- Market Cap
- CRVO 160.4M
- MSD 157.1M
- IPO Year
- CRVO N/A
- MSD N/A
- Fundamental
- Price
- CRVO $10.77
- MSD $7.56
- Analyst Decision
- CRVO Strong Buy
- MSD
- Analyst Count
- CRVO 5
- MSD 0
- Target Price
- CRVO $57.60
- MSD N/A
- AVG Volume (30 Days)
- CRVO 81.9K
- MSD 70.2K
- Earning Date
- CRVO 11-12-2024
- MSD 01-01-0001
- Dividend Yield
- CRVO N/A
- MSD 11.26%
- EPS Growth
- CRVO N/A
- MSD N/A
- EPS
- CRVO N/A
- MSD N/A
- Revenue
- CRVO $10,066,550.00
- MSD N/A
- Revenue This Year
- CRVO $54.67
- MSD N/A
- Revenue Next Year
- CRVO N/A
- MSD N/A
- P/E Ratio
- CRVO N/A
- MSD N/A
- Revenue Growth
- CRVO 116.29
- MSD N/A
- 52 Week Low
- CRVO $5.85
- MSD $6.11
- 52 Week High
- CRVO $26.38
- MSD $7.46
- Technical
- Relative Strength Index (RSI)
- CRVO 33.46
- MSD 37.71
- Support Level
- CRVO $11.95
- MSD $7.61
- Resistance Level
- CRVO $12.35
- MSD $7.71
- Average True Range (ATR)
- CRVO 1.04
- MSD 0.08
- MACD
- CRVO -0.16
- MSD -0.00
- Stochastic Oscillator
- CRVO 7.45
- MSD 10.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.